M. Dekkers

The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients.

M. Coenen, R. Lafyatis, M. Vonk, 2009, Human immunology.

Robust Detection of EGFR Copy Number Changes and EGFR Variant III: Technical Aspects and Relevance for Glioma Diagnostics

R. McLendon, P. Wesseling, J. Jeuken, 2009, Brain pathology.

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

P. Wesseling, J. Jeuken, A. Sijben, 2007, Laboratory Investigation.

Phenotypic and Genotypic Characterization of Orthotopic Human Glioma Models and Its Relevance for the Study of Anti‐glioma Therapy

P. Wesseling, W. Leenders, A. J. van der Kogel, 2008, Brain pathology.

Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas

I. Nagtegaal, F. Nagengast, W. Peters, 2007, Modern Pathology.